Mycophenolic acid
RxNorm 7145
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 7145 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Mycophenolic acid.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
INPrescribable
Ingredient (IN):
Mycophenolic acid
(Atom ID: 12252181)
PTPrescribable
Designated preferred name (PT):
Mycophenolic acid
(Atom ID: 232140)
FNPrescribable
Full form of descriptor (FN):
Mycophenolic acid (substance)
(Atom ID: 232145)
PTPrescribable
Designated preferred name (PT):
Mycophenolic acid-containing product
(Atom ID: 10807559)
FNPrescribable
Full form of descriptor (FN):
Product containing mycophenolic acid (medicinal product)
(Atom ID: 9260134)
Patient Education
Mycophenolate
Mycophenolate (CellCept) is used with other medications to help prevent transplant organ rejection (attack of the transplanted organ by the immune system of the person receiving the organ) in adults who have received heart and liver transplants and in adults and children 3 months of age and older who have received kidney transplants. Mycophenolate (Myfortic) is used with other medications to help prevent the body from rejecting kidney transplants. Mycophenolate is in a class of medications called immunosuppressive agents. It works by weakening the body's immune system so it will not attack and reject the transplanted organ.
[Learn More]
* Please review the disclaimer below.